ORLANDO, Fla., Feb. 12, 2019 /PRNewswire/ -- Medisafe, the leading medication management platform with over five million registered users, announced today a new program providing insights into medicine management behaviors and drug efficacy called Mediscoveries.
For over six years Medisafe has amassed proprietary data on medication adherence on over two billion successful medication doses. This self-reported aggregated data provides exclusive insight into consumer behaviors such as actual dosing schedules, reasons for skipping, switching patterns and overall adherence and persistence patterns to impact:
"Medisafe is uniquely positioned to provide consumer driven insights into medication adherence and its impact," says Omri Shor, CEO and Founder of Medisafe. "Our Mediscoveries program deep dives into the data to link real-time actual consumer medication consumption and overall medication management implications. 50% of medications are typically not taken as prescribed, so delivering this information to the healthcare eco-system is critical for managing cost, quality and medication effectiveness."
In the coming months, Medisafe will continue to share Mediscoveries across therapeutic areas.
The Medisafe team will be available at HIMSS 2019 at booth #4224 to share our ground breaking Mediscoveries around an asthma brand. To schedule a meeting please click here.
Contact:
Jennifer Butler, Chief Marketing Officer
617-650-1390
About Medisafe
Medisafe is the personalized medication management platform addressing non-adherence across a care journey, a $300 billion problem in the US alone. Medisafe's cloud-based mobile platform personalizes content, resources and interventions — such as educational videos, coupons and motivational messages — based on each user's regimen, condition and specific circumstance. Medisafe fosters collaboration among patients, their loved ones and healthcare professionals through caregiver tools and reports, and helps the healthcare professionals improve health outcomes and sustain quality care initiatives. Medisafe's almost five million registered patient and caregiver users who have recorded over one billion successful medication doses on their iOS and Android smartphones and tablets and contributed 180,000 user reviews that average 4.65 out of 5 stars in the App Store and Google Play app stores. Medisafe is a HIPAA and GDPR compliant solution and ISO 27001:2013 certified.
SOURCE Medisafe
